Wegovy-maker Novo Nordisk to spend $4.1 billion to boost US manufacturing

By Isabelle Yr Carlsson and Maggie Fick COPENHAGEN/LONDON (Reuters) – Obesity drug-maker Novo Nordisk will spend $4.1 billion to build a U.S. facility to fill injection pens for its hugely popular weight-loss treatment Wegovy and diabetes drug Ozempic, it said on Monday. Construction of the plant at Novo’s existing main U.S. manufacturing site in Clayton,…

Read More

Electric-vehicle maker Rivian simplifies output, cuts costs, aiming for first profit

By Abhirup Roy NORMAL, Illinois (Reuters) -Electric-vehicle maker Rivian’s drive to cut costs and turn its first profit has removed over 100 steps from the battery-making process, 52 pieces of equipment from the body shop and over 500 parts from the design of its flagship SUVs and pickups. The result of Rivian retooling its manufacturing…

Read More